TheraRadar

Pharma Intelligence, Simplified

Johnson & Johnson

160 active trials across 14 therapeutic areas

160
Active Trials
51
Phase 1
51
Phase 2
74
Phase 3
14
Therapeutic Areas
Portfolio Concentration: 71% of active trials in Oncology

Gastrointestinal

7 active / 12 total

Musculoskeletal

0 active / 6 total

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)